Mettler-Toledo International Inc. (NYSE:MTD) Director Hans Ulrich Maerki sold 2,600 shares of the company’s stock in a transaction on Monday, December 3rd. The stock was sold at an average price of $650.00, for a total transaction of $1,690,000.00. Following the transaction, the director now owns 9,487 shares of the company’s stock, valued at $6,166,550. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Hans Ulrich Maerki also recently made the following trade(s):
- On Tuesday, November 27th, Hans Ulrich Maerki sold 3,384 shares of Mettler-Toledo International stock. The shares were sold at an average price of $605.00, for a total value of $2,047,320.00.
Shares of Mettler-Toledo International stock opened at $590.78 on Friday. The company has a debt-to-equity ratio of 1.86, a current ratio of 1.39 and a quick ratio of 1.00. Mettler-Toledo International Inc. has a 1-year low of $521.79 and a 1-year high of $697.26. The stock has a market cap of $15.75 billion, a price-to-earnings ratio of 33.62, a price-to-earnings-growth ratio of 2.44 and a beta of 1.20.
Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, November 8th. The medical instruments supplier reported $5.12 earnings per share for the quarter, topping the Zacks’ consensus estimate of $4.99 by $0.13. Mettler-Toledo International had a return on equity of 93.15% and a net margin of 14.10%. The firm had revenue of $734.85 million during the quarter, compared to the consensus estimate of $738.23 million. During the same period last year, the business posted $4.36 EPS. The business’s revenue was up 5.2% compared to the same quarter last year. On average, sell-side analysts forecast that Mettler-Toledo International Inc. will post 20.23 earnings per share for the current year.
A number of institutional investors have recently modified their holdings of the business. Marshall Wace LLP grew its holdings in Mettler-Toledo International by 103.1% during the 3rd quarter. Marshall Wace LLP now owns 20,168 shares of the medical instruments supplier’s stock worth $12,282,000 after acquiring an additional 10,236 shares during the period. Clearbridge Investments LLC grew its holdings in Mettler-Toledo International by 25.2% during the 3rd quarter. Clearbridge Investments LLC now owns 226,802 shares of the medical instruments supplier’s stock worth $138,118,000 after acquiring an additional 45,646 shares during the period. Carnegie Capital Asset Management LLC grew its holdings in Mettler-Toledo International by 26.2% during the 3rd quarter. Carnegie Capital Asset Management LLC now owns 13,170 shares of the medical instruments supplier’s stock worth $7,903,000 after acquiring an additional 2,736 shares during the period. Morgan Stanley grew its holdings in Mettler-Toledo International by 39.3% during the 3rd quarter. Morgan Stanley now owns 104,076 shares of the medical instruments supplier’s stock worth $63,380,000 after acquiring an additional 29,388 shares during the period. Finally, Legal & General Group Plc grew its holdings in Mettler-Toledo International by 2.2% during the 3rd quarter. Legal & General Group Plc now owns 122,899 shares of the medical instruments supplier’s stock worth $74,842,000 after acquiring an additional 2,701 shares during the period. Hedge funds and other institutional investors own 93.80% of the company’s stock.
MTD has been the subject of a number of recent research reports. ValuEngine upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Friday, November 16th. Zacks Investment Research upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating and set a $621.00 price objective for the company in a report on Friday, October 12th. Morgan Stanley increased their price objective on Mettler-Toledo International from $529.00 to $572.00 and gave the company an “equal weight” rating in a report on Wednesday, October 10th. Finally, UBS Group initiated coverage on Mettler-Toledo International in a report on Tuesday, October 9th. They issued a “neutral” rating and a $625.00 price objective for the company. Ten investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $624.00.
ILLEGAL ACTIVITY NOTICE: “Hans Ulrich Maerki Sells 2,600 Shares of Mettler-Toledo International Inc. (MTD) Stock” was reported by The Lincolnian Online and is the property of of The Lincolnian Online. If you are accessing this news story on another website, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this news story can be accessed at https://www.thelincolnianonline.com/2018/12/08/hans-ulrich-maerki-sells-2600-shares-of-mettler-toledo-international-inc-mtd-stock.html.
About Mettler-Toledo International
Mettler-Toledo International Inc manufactures and supplies precision instruments and services worldwide. The company operates in five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. It offers weighing instruments for laboratory, industrial, packaging, logistics, and food retailing applications; analytical instruments for use in life science; various related analytical instruments and provides automated chemistry solutions used in drug and chemical compound discovery and development; and end-of-line product inspection systems used in production and packaging for food processing and packaging, pharmaceutical, packaged consumer goods, and other industries.
Recommended Story: Benefits of owning preferred stock
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.